Crescent Biopharma, Inc. Common Stock CBIO
$14.07
+4.22%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $32.67
- Implied Upside
- +132.2%
- Price Target Range
- $27.00 – $36.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-19 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $36 |
| 2026-10-06 | HC Wainwright & Co.Mitchell S. Kapoor |
Upgrades | Neutral → Buy | $36 |
| 2026-09-14 | WedbushRobert Driscoll |
Reiterates | Outperform | $27 |
| 2026-08-27 | WedbushRobert Driscoll |
Reiterates | Outperform | $27 |
| 2026-06-01 | HC Wainwright & Co.Mitchell S. Kapoor |
Downgrades | Buy → Neutral | — |
| 2026-03-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $25 → $22 |
| 2026-01-21 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $35 |
| 2025-08-27 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $25 |
| 2025-08-25 | JefferiesAkash Tewari |
Initiates coverage on | Buy | $26 |
| 2025-08-11 | HC Wainwright & Co.Mitchell S. Kapoor |
Initiates coverage on | Buy | $25 |
| 2025-07-14 | WedbushRobert Driscoll |
Initiates coverage on | Outperform | $27 |
| 2025-06-25 | StifelStephen Willey |
Initiates coverage on | Buy | $28 |
| 2025-06-18 | LifeSci CapitalCharles Zhu |
Initiates coverage on | Outperform | $22 |
| 2021-11-15 | Raymond JamesTimur Ivannikov |
Downgrades | Outperform → Market perform | — |
| 2021-08-06 | Raymond JamesSteven Seedhouse |
Maintains | Outperform | $285 → $270 |
| 2021-04-29 | Raymond JamesTimur Ivannikov |
Maintains | Outperform | $270 → $285 |
| 2021-02-10 | Piper SandlerTyler Van Buren |
Initiates coverage on | Overweight | $225 |
| 2021-02-04 | Raymond JamesDavid Novak |
Maintains | Outperform | $300 → $270 |
| 2019-01-04 | Oppenheimer |
Initiates coverage on | Outperform | $360 |
| 2018-06-21 | B. Riley SecuritiesGeorge Zavoico |
Downgrades | Buy → Neutral | $660 → $188 |
| 2018-02-12 | B. Riley SecuritiesGeorge Zavoico |
Maintains | Buy | $285 → $735 |
| 2018-02-09 | Chardan CapitalMadhu Kumar |
Maintains | Buy | $150 → $1125 |
| 2017-12-08 | B. Riley SecuritiesGeorge Zavoico |
Initiates coverage on | Buy | $285 |
| 2017-06-12 | Chardan CapitalMadhu Kumar |
Initiates coverage on | Buy | $150 |
| 2017-06-06 | Ladenburg ThalmannKevin DeGeeter |
Initiates coverage on | Buy | $165 |
| 2016-06-30 | Rodman & Renshaw |
Initiates coverage on | Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $14.07
- Market Cap
- $501.48 million
- 52-Week Range
- $8.72 – $27.41
- Average Volume
- 437K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.